… vedolizumab in patients with inflammatory bowel disease (OBSERV-IBD) study has included
all consecutive IBD patients who were treated with vedolizumab … of vedolizumab therapy on …

… that vedolizumab, like TNF antagonist therapies, does not impact the overall rate of
malignancies. However, in GEMINI LTS, vedolizumab was associated with lower rates of colon and …

… with inflammatory bowel disease (IBD). This product review outlines the unique mechanism
of vedolizumab … Citation21 Thus, the effect of vedolizumab is restricted to these areas. Since …

… Patients with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative
colitis, … The EMOTIVE study aimed to analyze the effect of vedolizumab on EIMs in a real-world …

… There are limited data on how vedolizumab (VDZ) impacts extraintestinal manifestations (EIMs)
in inflammatory bowel disease (IBD). The aim of this study was to determine the clinical …

… significant independent predictor for a response to vedolizumab in inflammatory bowel
diseases: a CRP of greater 8 mg/L at baseline. Reported side effects in this cohort were similar to …

… The impact of vedolizumab, a gut-selective … the impact of preoperative vedolizumab treatment
on the rate of postoperative complications in patients with inflammatory bowel disease [IBD…

… risk of intestinal infectious complications. In this context, the potential impact of vedolizumab
… The aim of our study was to evaluate the impact of preoperative use of vedolizumab on the …

… of vedolizumab-induced alterations in mucosal and systemic immunity to delineate the effects
of vedolizumab … We found that vedolizumab had little impact on the abundance, phenotype …

… Vedolizumab, which blocks the integrin α4β7, is used to treat patients with inflammatory bowel
diseases (IBD)… We investigated the effects of vedolizumab in a large international cohort of …